Erqi Liu Pollom

Erqi Pollom practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Erqi Pollom's NPI, 1932475902, was assigned on March 23, 2012. Erqi Pollom graduated from University Of Michigan Medical School in 2012. Erqi Pollom holds California license 127028.

Erqi Pollom's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Erqi Pollom's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Erqi Pollom is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Erqi Pollom to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account. Erqi Pollom's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Erqi Pollom practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Erqi Pollom's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Erqi Pollom is board certified in radiation oncology by the American Board of Radiology. Erqi Pollom is licensed in California.

Dmand AI lists anal cancer radiation, bone cancer radiation, brain cancer radiation, breast cancer radiation, colorectal cancer radiation, lung cancer radiation, pancreatic cancer radiation and prostate cancer radiation among the conditions Erqi Pollom treats.

CMS data shows 3,624 Medicare services from Erqi Pollom across 20 procedure codes in 2024, for 400 Medicare patients. Medicare paid $307,385 for them.

CMS counts 400 Medicare patients who saw Erqi Pollom in 2024. The largest group is 65 to 74, with 199 patients. 72% of them have high cholesterol, and 69% have high blood pressure. 24% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Erqi Pollom's median patient age at 64, with 45% women.

In 2024, Erqi Pollom wrote 64 Medicare Part D claims for 41 patients. 100% of them were for generic drugs. CMS names the drug for 24 of them, across 1 drug with 11 or more claims each, at $220 in total drug cost. In 2023, CMS named 27 claims across 2 drugs.

Erqi Pollom accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Erqi Pollom as offering telehealth.

Dmand AI links 207 papers to Erqi Pollom, published from 2014 to 2025. 2019 was the busiest year, with 23. The most frequent topics are Radiosurgery, Brain Neoplasms and Chemoradiotherapy. Erqi Pollom has published most often in Int J Radiat Oncol Biol Phys. Erqi Pollom's most frequent co-authors are Scott Gerard Soltys, MD, Daniel Tandel Chang, MD and Steven Daniel Chang, MD.

CMS Open Payments shows 27 general payments to Erqi Pollom from 7 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 68% of the total. Siemens Medical Solutions USA, Inc. paid the most, $21,499. It also lists 2 research payments totaling $1,048 in 2020.

Erqi Pollom graduated from University Of Michigan Medical School in 2012.

Erqi Pollom is in network with 5 carriers, including Aetna, United Healthcare and Blue Cross and Blue Shield of Kansas City. EPO plans come from the most carriers, 2. Check the plan with the practice before a visit.